Dr. Stefan Koch | White & Case LLP International Law Firm, Global Law Practice
Stefan Koch
Stefan Koch

Dr. Stefan Koch

Partner, Frankfurt

Stefan Koch is named as one of Germany’s best lawyers for Private Equity in the most recent Best Lawyers/Handelsblatt 2015 and is also listed as a Highly Recommended Lawyer for M&A and Private Equity & Venture Capital in Germany’s JUVE 2015 and 2016 rankings.


Stefan's practice is focused on mergers and acquisitions and private equity deals, as well as joint ventures and capital market transactions.

Drawing on his broad domestic and international experience, Stefan helps clients to navigate complex cross-border transactions, including both public and privately negotiated takeovers.

International both in outlook and approach, Stefan has played a leading role in a number of the Firm's legal teams, seamlessly coordinating advice across multiple offices and territories.

Representing corporate clients, investors and private equity firms, Stefan also offers strategic advice on a range of general corporate law issues, as well as technically complicated capital market, stock exchange and other regulatory matters.

Dual-qualified in New York and Germany, Stefan's international background includes 15 years working in the United States, in New York, and in Germany.

Bars and Courts

  • Rechtsanwalt
  • Attorney-at-Law, New York


  • Second State Exam, Hanseatic Higher Regional Court of Hamburg
  • Dr jur, University of Hamburg
  • LLM, New York University School of Law
  • First State Exam, University of Hamburg


  • German
  • English


Ardian (formerly Axa Private Equity), 2006-2016*

Advised Ardian on the 2016 acquisition of German Schwind eye-tech solutions GmbH as well as the previous acquisition of the railway sleepers business of Pfleiderer AG; the acquisition of CABB, a specialty chemicals company; the disposal of Alukon, a manufacture of roller shutters; and the disposal of Gealan, a manufacturer of PVC window profiles.

IK Investment Partners, 2016

Advised IK Investment Partners on its 2016 acquisition of ZytoService Deutschland GmbH.

Grünenthal, 2016

Advised Grünenthal on its US$235 million license agreement with AstraZeneca for Zurampic.

Groupe Legris Industries, 2016

Advised Groupe Legris Industries on its 2016 acquisition of Schiederwerk.

Duke Street, 2016

Advised Duke Street on its 2016 acquisition of Medi-Globe.

Battery Ventures, 2015

Advised Battery Ventures on its 2015 US$154 million sale of the German Trust International Group to NASDAQ-listed Sabre Corporation.

ACP Allianz Capital Partners and others, 2015

Advised an international syndicate consisting of Allianz Capital Partners, Borealis Infrastructure Management Inc., Infinity Investments SA and MEAG, the asset management arm of Münchener Rück, on its 2015 acquisition of Autobahn Tank & Rast GmbH, the German autobahn services company.

Super Group Limited, 2015

Advised Super Group Limited on its 2015 €153.5 million acquisition of the IN tIME group from funds advised by Equistone Partners Europe.

Halder, 2015

Advised Halder on the 2015 acquisition of PRAE-TURBO GmbH & Co. KG through a management buy-out.

Nordic Capital, 2014 – 2015

Advised Nordic Capital on its 2015 acquisition of the Sunrise Medical group from Equistone Partners Europe and on the 2014 acquisition of GHD GesundHeits GmbH Deutschland from IK InvestmentPartners.

Deutsche Bank AG, 2013

Advised Deutsche Bank on the acquisition of Xchanging Transaction Bank GmbH.

Forum Energy Technologies, 2013

Advised Forum Energy Technologies on the acquisition of Blohm + Voss Oil Tools from Star Capital.

Munksjö/ EQT, 2013

Advised Munksjö and its principal owner, EQT, in the creation of a global leader in high-quality specialty papers.

Merck KGaA, 2006 – 2015*

Advised Merck KGaA on the 2015 agreement by its Life Science business, Merck Millipore, to acquire the worldwide rights to an innovative protein detection technology from Singulex, the 2015 disposition of its drug discovery and developments solutions business to Eurofins SA, as well as previously on the US$7.2 billion acquisition of Millipore Corporation and the €4.9 billion disposal of its worldwide generics business to Mylan Inc.

*Includes matters worked on prior to joining White & Case


  • M&A Agreements in Germany, Ed., M. Jaletzke and W. Henle., Munich, (chapter on closing documents and common ancillary M&A Agreements) (co-author)
  • The International Comparative Legal Guide to M&A, Global Legal Group, London, 2010, 2009 and 2008, (co-author with M. Horbach)
  • Merger Control Regulations' Claim to the Absolute Truth?, Wirtschaft und Wettbewerb, Issue 11, pp. 1127, 2009, (Absolutheitsanspruch in der Fusionskontrolle?) (co-author with H. Henschen)
  • Influence by the Majority Shareholder after a Public Takeover, Going Public Magazin, p. 81– 82, May 2009, (Einflussnahme nach einer öffentlichen Übernahme) (co-author with M. Horbach)

Awards & Recognition

Highly Recommended Lawyer, Germany's Best Lawyers/Handelsblatt 2016

(Private Equity Law)

Highly Recommended Lawyer, JUVE 2016/2017

(Private Equity & Venture Capital)